Job Description:
Candidates should have strong AI/ML expertise, a solid biology background, and exposure to peptide and antibody design. If all three are limited, please prioritize AI/ML candidates with oligonucleotide/RNA experience.
The Importance of the Role
The client is expanding its capabilities in antisense oligonucleotide (ASO) therapeutics, including phosphorodiamidate morpholino oligomers (PMOs) and emerging oligonucleotide modalities, while advancing antibody, peptide, and other biologics discovery across multiple targets. To support this effort, we are integrating advanced machine learning (ML), generative and agentic artificial intelligence (AI), and data-driven modeling to accelerate discovery and optimization across modalities. The Research Scientist, AI/ML will help build reproducible computational frameworks that strengthen AI/ML-assisted design pipelines. The primary focus of this role is oligonucleotide therapeutics, with growing contributions to peptide, antibody and biologics programs.
Job Summary:
In this role, you will develop sequence-aware predictive models that prioritize oligonucleotide therapeutics by exon-skipping response, integrating sequence, thermodynamic, and pre-mRNA structural features, and extend these approaches across PMOs, gapmers, siRNA–PMO hybrids, and conjugate designs. You will also contribute to AI/ML-driven de novo design and multi-objective optimization of antibodies, peptides, and other biologics, including modeling of protein structure and antibody–antigen interactions.
Working closely with chemists, biologists, and data scientists, you will benchmark and prospectively validate model predictions, helping turn computational insights into experimentally tested designs and expanding the client’s cross-modality design and decision-support capabilities.
Key Responsibilities:
Required Skills & Education: